Patterns of on-demand medication use in patients with hereditary angioedema treated long-term with prophylactic subcutaneous C1-inhibitor

Схожие документы

• Long-Term Efficacy of Subcutaneous C1 Inhibitor in Pediatric Patients with Hereditary Angioedema
  по: Levy, Donald, et al.
  Опубликовано: (2020)
• Advances in Hereditary Angioedema: The Prevention of Angioedema Attacks With Subcutaneous C1-Inhibitor Replacement Therapy
  по: Lumry, William, et al.
  Опубликовано: (2020)
• Hereditary angioedema C1-inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
  по: Farkas, Henriette, et al.
  Опубликовано: (2019)
• Hereditary angioedema C1-esterase inhibitor replacement therapy and coexisting autoimmune disorders: findings from a claims database
  по: Farkas, Henriette, et al.
  Опубликовано: (2020)
• Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial
  по: Levy, Donald S., et al.
  Опубликовано: (2020)